-
Whenever the research enterprise is pushed into a new direction, some different ethical issues and considerations arise. Experts say this likely will be the case as more research institutions engage in comparative effectiveness research (CER), as well.
-
The U.S. Food and Drug Administration requires that new psychiatric drugs be tested against placebo to ensure that they are effective.
-
Another voice has been added t o the chorus of those blaming excessive regulatory oversight for a slowdown in vital research.
-
Despite the value that placebo controls bring to psychiatric research, they are not appropriate for all clinical trials of antidepressants and anti-anxiety medications.
-
More than three dozen institutions who participated in a study of IRB response times will be receiving individualized reports that show how their institution stacks up against the rest of the group.
-
Most principal investigators (PIs) are not very good at conveying complex ideas in simple terms, an IRB and research expert says.
-
-
-
In a retrospective study of more than 5300 non-obstetric dilation and curettage (D&C) procedures between 1995 and 2006, these Austrian investigators found that the rate of intraoperative complications was only 1.9%.
-
A large retrospective cohort time series compared strategies to prevent infectious complications of medical abortion at Planned Parenthood Federation of America (PPFA)-affiliated clinics.
